Axon-glial signaling and the glial support of axon function

Annual Review of Neuroscience

Volumn 31, Issue , 2008, Pages 535-561

  Nave, Klaus Armin ^a   Trapp, Bruce D ^b  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Axonal transport; Energy metabolism; Growth factors; Myelination; Neurodegenerative diseases; Oligodendrocytes; Schwann cells

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINERGIC RECEPTOR; ISOPROTEIN; MYELIN BASIC PROTEIN; NERVE GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN;

ATAXIA; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL MEMBRANE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DEMYELINATING NEUROPATHY; DEMYELINATION; ELECTRIC ACTIVITY; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; EXPERIMENTAL MODEL; GENE DUPLICATION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE SWITCHING; GENETIC DISORDER; GENETIC POLYMORPHISM; GLIA; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MULTIPLE SCLEROSIS; MYELIN DEFICIENCY; MYELIN SHEATH; MYELINATION; NERVE CELL; NERVE CELL MEMBRANE POTENTIAL; NERVE CONDUCTION; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER DEGENERATION; NERVE FUNCTION; NERVE GROWTH; NEUROFILAMENT; NONHUMAN; NONMYELINATED NERVE; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PEROXISOME; POINT MUTATION; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SCHWANN CELL; SIGNAL TRANSDUCTION;

ANIMALS; AXONS; CELL COMMUNICATION; CELL SURVIVAL; DEMYELINATING DISEASES; HUMANS; MYELIN PROTEINS; NERVE FIBERS, MYELINATED; NERVOUS SYSTEM; OLIGODENDROGLIA; SCHWANN CELLS; SIGNAL TRANSDUCTION;

EID: 43249098296     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.30.051606.094309     Document Type: Review

References (207)

1. Adlkofer K, Lai C. 2000. Role of neuregulins in glial cell development. Glia 29:104-11
2. Aguayo AJ, Charron L, Bray GM. 1976. Potential of Schwann cells from unmyelinated nerves to produce myelin: a quantitative ultrastructural and radiographic study. J. Neurocytol. 5:565-73
3. Alberti S, Gregorio EA, Spadella CT, Cojocel C. 2007. Localization and irregular distribution of Na,K-ATPase in myelin sheath from rat sciatic nerve. Tissue Cell 39:195-201
4. Andrews H, White K, Thomson C, Edgar J, Bates D, et al. 2006. Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse. J. Neurosci. Res. 83:1533-39
5. Atanasoski S, Scherer SS, Sirkowski E, Leone D, Garratt AN, et al. 2006. ErbB2 signaling in Schwann cells is mostly dispensable for maintenance of myelinated peripheral nerves and proliferation of adult Schwann cells after injury. J. Neurosci. 26:2124-31
6. Barres BA, Raff MC. 1993. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature 361:258-60
7. Barres BA, Raff MC, Gaese F, Bartke I, Dechant G, Barde YA. 1994. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367:371-75
8. Barron KD, Dentinger MP, Csiza CK, Keegan SM, Mankes R. 1987. Abnormalities of central axons in a dysmyelinative rat mutant. Exp. Mol. Pathol. 47:125-42
9. Bartsch U. 2003. Neural CAMS and their role in the development and organization of myelin sheaths. Front Biosci. 8:477-90
10. Bartsch U, Montag D, Bartsch S, Schachner M. 1995. Multiply myelinated axons in the optic nerve of mice deficient for the myelin-associated glycoprotein. Glia 14:115-22
11. Bartsch S, Montag D, Schachner M, Bartsch U. 1997. Increased number of unmyelinated axons in optic nerves of adult mice deficient in the myelin-associated glycoprotein (MAG). Brain Res. 762:231-34
12. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, et al. 1995. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373:339-41
13. Berger P, Niemann A, Suter U. 2006. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Glia 54:243-57
14. Bifulco M, Laezza C, Stingo S, Wolff J. 2002. 2′,3′-cyclic nucleotide 3′-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc. Natl. Acad. Sci. USA 99:1807-12
15. Boerkoel CF, Takashima H, Garcia CA, Olney RK, Johnson J, et al. 2002. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann. Neurol. 51:190-201
16. Boison D, Bussow H, D'Urso D, Muller HW, Stoffel W. 1995. Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J. Neurosci. 15:5502-13
17. Bonavita S, Schiffmann R, Moore DF, Frei K, Choi B, et al. 2001. Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations. Neurology 56:785-88
18. Boucher TJ, Okuse K, Bennett DLH, Munson JB, Wood JN, McMahon SB. 2000. Potent analgesic effects of GDNF in neuropathic pain states. Science 290:124-27
19. Brady ST, Witt AS, Kirkpatrick LL, de Waegh SM, Readhead C, et al. 1999. Formation of compact myelin is required for maturation of the axonal cytoskeleton. J. Neurosci. 19:7278-88
20. Braun PE, Sandillon F, Edwards A, Matthieu JM, Privat A. 1988. Immunocytochemical localization by electron microscopy of 2′3′- cyclic nucleotide 3′-phosphodiesterase in developing oligodendrocytes of normal and mutant brain. J. Neurosci. 8:3057-66
21. Britsch S. 2007. The neuregulin-I/ErbB signaling system in development and disease. Adv. Anat. Embryol. Cell Biol. 190:1-65
22. Brown AM, Tekkök SB, Ransom BR. 2003. Glycogen regulation and functional role in mouse white matter. J. Physiol. 549:501-12
23. Bullock TH, Moore JK, Fields RD. 1984. Evolution of myelin sheaths: both lamprey and hagfish lack myelin. Neurosci. Lett. 48:145-48
24. Calaora V, Rogister B, Bismuth K, Murray K, Brandt H, et al. 2001. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J. Neurosci. 21:4740-51
25. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL. 1996. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17:229-43
26. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. 1996. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383:716-19
27. Chan JR, Cosgaya JM, Wu YJ, Shooter EM. 2001. Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc. Natl. Acad. Sci. USA 98:14661-68
28. Chan JR, Watkins TA, Cosgaya JM, Zhang C, Chen L, et al. 2004. NGF controls axonal receptivity to myelination by Schwann Cells or oligodendrocytes. Neuron 43:183-91
29. Chao MV, Rajagopal R, Lee FS. 2006. Neurotrophin signalling in health and disease. Clin. Sci. 110:167-73
30. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, et al. 2000. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc. Natl. Acad. Sci. USA 97:7585-90
31. Chen S, Rio C, Ji RR, Dikkes P, Coggeshall RE, et al. 2003. Disruption of ErbB receptor signaling in adult nonmyelinating Schwann cells causes progressive sensory loss. Nat. Neurosci. 6:1186-93
32. Colello RJ, Pott U. 1997. Signals that initiate myelination in the developing mammalian nervous system. Mol. Neurobiol. 15:83-100
33. Colello RJ, Pott U, Schwab ME. 1994. The role of oligodendrocytes and myelin on axon maturation in the developing rat retinofugal pathway. J. Neurosci. 14:2594-605
34. Colognato H, Baron W, Avellana-Adalid V, Relvas JB, Baron-Van Evercooren A, et al. 2002. CNS integrins switch growth factor signalling to promote target-dependent survival. Nat. Cell Biol. 4:833-41
35. Coman I, Barbin G, Charles P, Zalc B, Lubetzki C. 2005. Axonal signals in central nervous system myelination, demyelination and remyelination. J. Neurol. Sci. 233:67-71
36. Corfas G, Velardez MO, Ko CP, Ratner N, Peles E. 2004. Mechanisms and roles of axon-Schwann cell interactions. J. Neurosci. 24:9250-60
37. Cosgaya JM, Chan JR, Shooter EM. 2002. The neurotrophin receptor p75NTR as a positive modulator of myelination. Science 298:1245-48
38. Davis AD, Weatherby TM, Hartline DK, Lenz PH. 1999. Myelin-like sheaths in copepod axons. Nature 398:571
39. De Angelis DA, Braun PE. 1996. 2′,3′-cyclic nucleotide 3′-phosphodiesterase binds to actin-based cytoskeletal elements in an isoprenylation-dependent manner. J. Neurochem. 67:943-51
40. Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, et al. 1996. Induction of myelination in the central nervous system by electrical activity. Proc. Natl. Acad. Sci. USA 93:9887-92
41. de Waegh SM, Lee VM, Brady ST. 1992. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451-63
42. Dhaunchak A, Nave KA. 2007. A common mechanism of PLP/DM20 misfolding leading to cysteine-mediated ER retention in oligodendrocytes and Pelizaeus-Merzbacher disease. Proc. Natl. Acad. Sci. USA 104:17815-18
43. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang KC, et al. 2002. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35:283-90
44. Donaldson HH, Hoke GW. 1905. The areas of the axis cylinder and medullary sheath as seen in cross sections of the spinal nerves of vertebrates. J. Comp. Neurol. 15:1-16
45. Du Y, Fischer TZ, Lee LN, Lercher LD, Dreyfus CF. 2003. Regionally specific effects of BDNF on oligodendrocytes. Dev. Neurosci. 25:116-26
46. Dubois-Dalcq M, Behar T, Hudson L, Lazzarini RA. 1986. Emergence of three myelin proteins in oligodendrocytes cultured without neurons. J. Cell Biol. 102:384-92
47. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, et al. 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381:789-93
48. Edgar JM, McLaughlin M, Barrie JA, McCulloch MC, Garbern J, Griffiths IR. 2004a. Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene. Acta Neuropathol. (Berl.) 107:331-35
49. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, et al. 2004b. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J. Cell Biol. 166:121-31
50. Einheber S, Bhat MA, Salzer JL. 2006. Disrupted axo-glial junctions result in accumulation of abnormal mitochondria at nodes of Ranvier. Neuron Glia Biol. 2:165-74
51. Esper RM, Loeb JA. 2004. Rapid axoglial signaling mediated by neuregulin and neurotrophic factors. J. Neurosci. 24:6218-27
52. Esper RM, Pankonin MS, Loeb JA. 2006. Neuregulins: versatile growth and differentiation factors in nervous system development and human disease. Brain Res. Rev. 51:161-75
53. Ey B, Kobsar I, Blazyca H, Kroner A, Martini R. 2007. Visualization of degenerating axons in a dysmyelinating mouse mutant with axonal loss. Mol. Cell Neurosci. 35:153-60
54. Fabricius C, Berthold CH, Rydmark M. 2003. Axoplasmic organelles at nodes of Ranvier. II. Occurrence and distribution in large myelinated spinal cord axons of the adult cat. J. Neurocytol. 22:941-54
55. Falls DL. 2003. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 284:14-30
56. Fern R, Davis P, Waxman SG, Ransom BR. 1998, Axon conduction and survival in CNS white matter during energy deprivation: a developmental study. J. Neurophysiol. 79:95-105
57. Fernandez PA, Tang DG, Cheng L, Prochiantz A, Mudge AW, Raff MC. 2000. Evidence that axon-derived neuregulin promotes oligodendrocyte survival in the developing rat optic nerve. Neuron 28:81-90
58. Ferreirinha F, Quattrini A, Pirozzi M, Valsecchi V, Dina G, et al. 2004. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Invest. 113:231-42
59. Fields RD, Burnstock G. 2006. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 7:423-36
60. Flores AI, Mallon BS, Matsui T, Ogawa W, Rosenzweig A, et al. 2000. Akt-mediated survival of oligodendrocytes induced by neuregulins. J. Neurosci. 20:7622-30
61. Friede RL. 1972. Control of myelin formation by axon caliber (with a model of the control mechanism). J. Comp. Neurol. 144:233-52
62. Garbern JY. 2007. Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis. Cell. Mol. Life Sci. 64:50-65
63. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, et al. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-61
64. Garcia-Fresco GP, Sousa AD, Pillai AM, Moy SS, Crawley JN, et al. 2006. Disruption of axoglial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axons. Proc. Natl. Acad. Sci. USA 103:5137-42
65. Garratt AN, Britsch S, Birchmeier C. 2000a. Neuregulin, a factor with many functions in the life of a Schwann cell. Bioessays 22:987-96
66. Garratt AN, Voiculescu O, Topilko P, Charnay P, Birchmeier C. 2000b. A dual role of erbB2 in myelination and in expansion of the Schwann cell precursor pool. J. Cell Biol. 148:1035-46
67. Gatzinsky KP, Holtmann B, Daraie B, Berthold CH, Sendtner M. 2003. Early onset of degenerative changes at nodes of Ranvier in alpha-motor axons of Cntf null (-/-) mutant mice. Glia 42:340-49
68. Goto K, Kurihara T, Takahashi Y, Kondo H. 1990. Expression of genes for the myelin-specific proteins in oligodendrocytes in vivo demands the presence of axons. Neurosci. Lett. 117:269-74
69. Gow A, Lazzarini RA. 1996. A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat. Genet. 13:422-28
70. Gravel M, DeAngelis D, Braun PE. 1994. Molecular cloning and characterization of rat brain 2′,3′-cyclic nucleotide 3′-phosphodiesterase isoform 2. J. Neurosci. Res. 38:243-47
71. Gravel M, Peterson J, Yong VW, Kottis V, Trapp B, Braun PE. 1996. Overexpression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol. Cell Neurosci. 7:453-66
72. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, et al. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-13
73. Haney CA, Sahenk Z, Li C, Lemmon VP, Roder J, Trapp BD. 1999. Heterophilic binding of L1 on unmyelinated sensory axons mediates Schwann cell adhesion and is required for axonal survival. J. Cell Biol. 146:1173-84
74. Hartline DK, Colman DR. 2007. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr. Biol. 17:R29-35
75. Hawkins BT, Davis TP. 2005. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57:173-85
76. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, et al. 1994. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266:1062-64
77. Herculano-Houzel S, Lent R. 2005. Isotropic fractionator: a simple, rapid method for the quantification of total cell and neuron numbers in the brain. J. Neurosci. 25:2518-21
78. Hertz L, Zielke HR. 2004. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 27:735-43
79. Hoke A, Ho T, Crawford TO, LeBel C, Hilt D, Griffin JW. 2003. Glial cell line derived neurotrophic factor alters axon Schwann cell units and promotes myelination in unmyelinated nerve fibers. J. Neurosci. 23:561-67
80. Hollenbeck PJ, Saxton WM. 2005. The axonal transport of mitochondria. J. Cell Sci. 118:5411-19
81. Horiuchi K, Zhou HM, Kelly K, Manova K, Blobel CP. 2005. Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. Dev. Biol. 283:459-71
82. Hu X, Hicks CW, He W, Wong P, Macklin WB, et al. 2006. Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9:1520-25
83. Huang EJ, Reichardt LF. 2001. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24:677-736
84. Hudson LD, Berndt JA, Puckett C, Kozak CA, Lazzarini RA. 1987. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc. Natl. Acad. Sci. USA 84:1454-58
85. Hudson LD, Puckett C, Berndt J, Chan J, Gencic S. 1989. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. Proc. Natl. Acad. Sci. USA 86:8128-31
86. Inoue Y, Nakamura R, Mikoshiba K, Tsukada Y. 1981. Fine structure of the central myelin sheath in the myelin deficient mutant Shiverer mouse, with special reference to the pattern of myelin formation by oligodendroglia. Brain Res. 219:85-94
87. Inoue K. 2005. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6:1-16
88. Inoue K, Tanabe Y, Lupski JR. 1999. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann. Neurol. 46:313-38
89. Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, et al. 2006. Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J. Neurosci. 26:8206-16
90. Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, et al. 2006. Astrocytes promote myelination in response to electrical impulses. Neuron 49:823-32
91. Jessen KR, Mirsky R. 2005. The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 6:671-82
92. Johnston AW, McKusick VA. 1962. A sex-linked recessive form of spastic paraplegia. Am. J. Hum. Genet. 14:83-94
93. Jung M, Sommer I, Schachner M, Nave KA. 1996. Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice. J. Neurosci. 16:7920-29
94. Kagitani-Shimono K, Mohri I, Oda H, Ozono K, Suzuki K, et al. 2006. Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis. Neuropathol. Appl. Neurobiol. 32:64-73
95. Kassmann CM, Lappe-Siefke C, Baes M, Brugger B, Mildner A, et al. 2007. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 39:969-76
96. Kidd GJ, Hauer PE, Trapp BD. 1990. Axons modulate myelin protein messenger RNA levels during central nervous system myelination in vivo. J. Neurosci. Res. 26:409-18
97. Kirkpatrick LL, Witt AS, Payne HR, Shine HD, Brady ST. 2001. Changes in microtubule stability and density in myelin-deficient shiverer mouse CNS axons. J. Neurosci. 21:2288-97
98. Klämbt C, Hummel T, Granderath S, Schimmelpfeng K. 2001. Glial cell development in Drosophila. Int. J. Dev. Neurosci. 19:373-78
99. Klugmann M, Schwab MH, Puhlhofer A, Schneider A, Zimmermann F, et al. 1997. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18:59-70
100. Kumar S, Kahn MA, Dinh L, de Vellis J. 1998. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo. J. Neurosci. Res. 54:754-65
101. Lai C, Brow MA, Nave KA, Noronha AB, Quarles RH, et al. 1987. Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing. Proc. Natl. Acad. Sci. USA 84:4337-41
102. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, et al. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33:366-74
103. Lassmann H, Bartsch LT, Montag D, Schachner M. 1997. Dying-back oligodendrogliopathy: a late sequel of myelin-associated glycoprotein deficiency. Glia 19:104-10
104. Lee J, Gravel M, Zhang R, Thibault P, Braun PE. 2005. Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J. Cell Biol. 170:661-73
105. Lee J, O'Neill RC, Park MW, Gravel M, Braun PE. 2006. Mitochondrial localization of CNP2 is regulated by phosphorylation of the N-terminal targeting signal by PKC: implications of a mitochondrial function for CNP2 in glial and nonglial cells. Mol. Cell Neurosci. 31:446-62
106. Leimeroth R, Lobsiger C, Lussi A, Taylor V, Suter U, Sommer L. 2002. Membrane bound neuregulin1 type III actively promotes Schwann cell differentiation of multipotent progenitor cells. Dev. Biol. 246:245-58
107. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, et al. 1994. Myelination in the absence of myelin-associated glycoprotein. Nature 369:747-50
108. (2+) exchange in spinal cord white matter injury at physiological temperature. J. Neurophysiol. 84:1116-19
109. Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, et al. 2002. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8:620-24
110. Magistretti PJ. 2006. Neuron-glia metabolic coupling and plasticity. J. Exp. Biol. 209:2304-11
111. Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL. 2006. Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53:372-81
112. Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F. 1998. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 50:1397-401
113. Martini R, Schachner M. 1986. Immunoelectron microscopic localization of neural cell adhesion molecules (L1, N-CAM, and MAG) and their shared carbohydrate epitope and myelin basic protein in developing sciatic nerve. J. Cell Biol. 103:2439-48
114. Maurel P, Einheber S, Galinska J, Thaker P, Lam I, et al. 2007. Nectin-like proteins mediate axon Schwann cell interactions along the internode and are essential for myelination. J. Cell Biol. 178:861-74
115. Maurel P, Salzer JL. 2000. Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J. Neurosci. 20:4635-45
116. McFerran B, Burgoyne R. 1997. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase is associated with mitochondria in diverse adrenal cell types. J. Cell Sci. 110:2979-85
117. McPhilemy K, Griffiths IR, Mitchell LS, Kennedy PG. 1991. Loss of axonal contact causes down-regulation of the PLP gene in oligodendrocytes: evidence from partial lesions of the optic nerve. Neuropathol. Appl. Neurobiol. 17:275-87
118. McTigue DM, Horner PJ, Stokes BT, Gage FH. 1998. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci. 18:5354-65
119. Meier C, Bischoff A. 1975. Oligodendroglial cell development in jimpy mice and controls. An electron-microscopic study in the optic nerve. J. Neurol. Sci. 26:517-28
120. Merzbacher L. 1909. Gesetzmaessigkeiten in der Vererbung und Verbreitung verschiedener hereditaer-familiaerer Erkrankungen. Arch. Rass. Ges. Biol. 6:172-98
121. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, et al. 2004. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304:700-3
122. Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW, Lichtman JW. 2007. Imaging axonal transport of mitochondria in vivo. Nat. Methods 4:559-61
123. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, et al. 1994. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13:229-46
124. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, et al. 1996. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382:76-79
125. Morrissey TK, Levi AD, Nuijens A, Sliwkowski MX, Bunge RP. 1995. Axon induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. Proc. Natl. Acad. Sci. USA 92:1431-35
126. Murray MA. 1968. An electron microscopic study of the relationship between axon diameter and the initiation of myelin production in the peripheral nervous system. Anat. Rec. 161:337-52
127. Mutsaers SE, Carroll WM. 1998. Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve. Acta Neuropathol. 96:139-43
128. Nave KA, Boespflug-Tanguy O. 1996. Developmental defects of myelin formation: from X-linked mutations to human dysmyelinating diseases. Neuroscientist 2:33-43
129. Nave KA, Lai C, Bloom FE, Milner RJ. 1986. Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc. Natl. Acad. Sci. USA 83:9264-68
130. Nave KA, Salzer JL. 2006. Axonal regulation of myelination by neuregulin 1. Curr. Opin. Neurobiol. 16:492-500
131. Nave KA, Sereda MW, Ehrenreich H. 2007. Mechanisms of disease: inherited demyelinating neuropathies - from basic to clinical research. Nat. Clin. Pract. Neurol. 3:453-64
132. Nixon RA. 1982. Increased axonal proteolysis in myelin-deficient mutant mice. Science 215:999-1001
133. Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, et al. 2004. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J. Neurosci. 24:6724-32
134. Paratcha G, Ledda F, Ibanez CF. 2003. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113:867-79
135. Paratore C, Goerich DE, Suter U, Wegner M, Sommer L. 2001. Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development 128:3949-61
136. Pelizaeus E 1885. Ueber eine eigentumliche Form spastischer Lahmung mit Cerebralerscheinungen auf hereditarer Grundlage (Multiple Sklerose). Arch. Psychiat. Nervenkr. 16:698-710
137. Peters A, Palay SL, Webster H deF. 1991. The Fine Structure of the Nervous System. New York: Oxford Univ. Press. 3rd ed.
138. Pichel JG, Shen L, Shang HZ, Granholm AC, Drago J, et al. 1996. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382:73-76
139. Raine CS, Cross AH. 1989. Axonal dystrophy as a consequence of long-term demyelination. Lab. Invest. 60:714-25
140. Rasband MN, Tayler J, Kaga Y, Yang Y, Lappe-Siefke C, et al. 2005. CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 50:86-90
141. Raskind WH, Williams CA, Hudson LD, Bird TD. 1991. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 49:1355-60
142. Readhead C, Schneider A, Griffiths I, Nave KA. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583-95
143. Riethmacher D, Sonnenberg-Riethmacher E, Brinkmann V, Yamaai T, Lewin GR, Birchmeier C. 1997. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389:725-30
144. Roach A, Takahashi N, Pravtcheva D, Ruddle F, Hood L. 1985. Chromosomal mapping of mouse myelin basic protein gene and structure and transcription of the partially deleted gene in shiverer mutant mice. Cell 42:149-55
145. Rosenberg SS, Ng BK, Chan JR. 2006. The quest for remyelination: a new role for neurotrophins and their receptors. Brain Pathol. 16:288-94
146. Rosenbluth J. 1980. Central myelin in the mouse mutant shiverer. J. Comp. Neurol. 194:639-48
147. Rosenbluth J, Nave KA, Mierzwa A, Schiff R. 2006. Subtle myelin defects in PLP-null mice. Glia 54:172-82
148. Rosenfeld J, Friedrich VL Jr. 1983. Axonal swellings in jimpy mice: Does lack of myelin cause neuronal abnormalities? Neuroscience 10:959-66
149. Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, et al. 2007. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc. Natl. Acad. Sci. USA 104:8131-36
150. Sahenk Z, Nagaraja HN, McCracken BS, King WM, Freimer ML, et al. 2005. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology 65:681-89
151. Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, et al. 2005. High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8:468-75
152. Salzer JL, Williams AK, Glaser L, Bunge RP. 1980. Studies of Schwann cell proliferation. II. Characterization of the stimulation and specificity of the response to a neurite membrane fraction. J. Cell Biol. 84:753-66
153. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M. 1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382:70-73
154. Sandell JH, Peters A. 2003. Disrupted myelin and axon loss in the anterior commissure of the aged rhesus monkey. J. Comp. Neurol. 466:14-30
155. Saugier-Veber P, Munnich A, Bonneau D, Rozet JM, Le Merrer M, et al. 1994. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat. Genet. 6:257-62
156. Scherer SS, Vogelbacker HH, Kamholz J. 1992. Axons modulate the expression of proteolipid protein in the CNS. J. Neurosci. Res. 32:138-48
157. Schneider A, Montague P, Griffiths I, Fanarraga M, Kennedy P, et al. 1992. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358:758-61
158. Schroering A, Carey DJ. 1998. Sensory and motor neuron-derived factor is a transmembrane heregulin that is expressed on the plasma membrane with the active domain exposed to the extracellular environment. J. Biol. Chem. 273:30643-50
159. Schweigreiter R, Roots BI, Bandtlow CE, Gould RM. 2006. Understanding myelination through studying its evolution. Int. Rev. Neurobiol. 73:219-73
160. Senderek J, Hermanns B, Lehmann U, Bergmann C, Senderek J, et al. 2000. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp16Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met. Brain Pathol. 10:235-48
161. Sendtner M, Carroll P, Holtmann B, Hughes RA, Thoenen H. 1994. Ciliary neurotrophic factor. J Neurobiol. 25:1436-53
162. Shah NM, Marchionni MA, Isaacs I, Stroobant P, Anderson DJ. 1994. Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77:349-60
163. Sherwood CC, Stimpson CD, Raghanti MA, Wildman DE, Uddin M, et al. 2006. Evolution of increased glia-neuron ratios in the human frontal cortex. Proc. Natl. Acad. Sci. USA 103:13606-11
164. Simons M, Krämer EM, Thiele C, Stoffel W, Trotter J. 2000. Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J. Cell Biol. 151:143-54
165. + channels. J. Neurophysiol. 95:1683-95
166. Smith KJ, Blakemore WF, Murray JA, Patterson RC. 1982. Internodal myelin volume and axon surface area. A relationship determining myelin thickness? J. Neurol. Sci. 55:231-46
167. Southwood CM, Garbern J, Jiang W, Gow A. 2002. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36:585-96
168. Spencer PS, Sabri MI, Schaumburg HH, Moore CL. 1979. Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann. Neurol. 5:501-7
169. Spiegel I, Adamsky K, Eshed Y, Milo R, Sabanay H, et al. 2007. A central role for Necl4 (Syn-CAM4) in Schwann cell-axon interaction and myelination. Nat. Neurosci. 10:861-69
170. Sporkel O, Uschkureit T, Bussow H, Stoffel W. 2002. Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development. Glia 37:19-30
171. Springer JE, Seeburger JL, He J, Gabrea A, Blankenhorn EP, Bergman LW. 1995. cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle. Exp. Neurol. 131:47-52
172. Stecca B, Southwood CM, Gragerov A, Kelley KA, Friedrich VL Jr, Gow A. 2000. The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. J. Neurosci. 20:4002-10
173. Stevens B, Fields RD. 2000. Response of Schwann cells to action potentials in development. Science 287:2267-71
174. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. 2002. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 36:855-68
175. 2+ exchanger. J. Neurosci. 12:430-39
176. Sussman CR, Vartanian T, Miller RH. 2005. The ErbB4 neuregulin receptor mediates suppression of oligodendrocyte maturation. J. Neurosci. 25:5757-62
177. Suter U, Scherer SS. 2003. Disease mechanisms in inherited neuropathies. Nat. Rev. Neurosci. 4:714-26
178. Suter-Crazzolara C, Unsicker K. 1994. GDNF is expressed in two forms in many tissues outside the CNS. NeuroReport 20:2486-88
179. Takahashi R, Yokoji H, Misawa H, Hayashi M, Hu J, Deguchi T. 1994. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat. Genet. 7:79-84
180. Taniike M, Mohri I, Eguchi N, Beuckmann CT, Suzuki K, Urade Y. 2002. Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model. J. Neurosci. 22:4885-96
181. Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, et al. 2005. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681-94
182. Thippeswamy T, McKay JS, Morris R, Quinn J, Wong LF, Murphy D. 2005. Glial-mediated neuroprotection: evidence for the protective role of the NO-cGMP pathway via neuron-glial communication in the peripheral nervous system. Glia 49:197-210
183. Trapp BD, Andrews SB, Cootauco C, Quarles R. 1989. The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J. Cell Biol. 109:2417-26
184. Trapp BD, Bernier L, Andrews SB, Colman DR. 1988. Cellular and subcellular distribution of 2′,3′-cyclic nucleotide 3′-phosphodiesterase and its mRNA in the rat central nervous system. J. Neurochem. 51:859-68
185. Trapp BD, Nave KA. 2008. Axonal degeneration in multiple sclerosis. Annu. Rev. Neurosci. 31:247-69
186. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278-85
187. Trupp M, Rydén M, Jörnvall H, Funakoshi H, Timmusk T, et al. 1995. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130:137-48
188. Ueda H, Levine JM, Miller RH, Trapp BD. 1999. Rat optic nerve oligodendrocytes develop in the absence of viable retinal ganglion cell axons. J. Cell Biol. 146:1365-74
189. Van Vught PW, Van Wijk J, Bradley TE, Plasmans D, Jakobs ME, et al. 2007. Ciliary neurotrophic factor null alleles are not a risk factor for Charcot-Marie-Tooth disease, hereditary neuropathy with pressure palsies and amyotrophic lateral sclerosis. Neuromuscul. Disord. 17:964-67
190. Vartanian T, Fischbach G, Miller R. 1999. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc. Natl. Acad. Sci. USA 96:731-35
191. Vartanian T, Goodearl A, Viehover A, Fischbach G. 1997. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. J. Cell Biol. 137:211-20
192. Vega C, Martiel JL, Drouhault D, Burckhart MF, Coles JA. 2003. Uptake of locally applied deoxyglucose, glucose and lactate by axons and Schwann cells of rat vagus nerve. J. Physiol. 546:551-64
193. Vogel US, Thompson RJ. 1988. Molecular structure, localization, and possible functions of the myelin-associated enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase. J. Neurochem. 50:1667-77
194. Voyvodic JT. 1989. Target size regulates calibre and myelination of sympathetic axons. Nature 342:430-33
195. Watanabe M, Sakurai Y, Ichinose T, Aikawa Y, Kotani M, Itoh K. 2006. Monoclonal antibody Rip specifically recognizes 2′,3′-cyclic nucleotide 3′-phosphodiesterase in oligodendrocytes. J. Neurosci. Res. 84:525-33
196. Weinberg HJ, Spencer PS. 1976. Studies on the control of myelinogenesis. Evidence for neuronal regulation of myelin production. Brain Res. 113:363-78
197. Weiss MD, Hammer J, Quarles RH. 2000. Oligodendrocytes in aging mice lacking myelin-associated glycoprotein are dystrophic but not apoptotic. J. Neurosci. Res. 62:772-80
198. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, et al. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J. Neurosci. 27:7717-30
199. Wilkins A, Majed H, Layfield R, Compston A, Chandran S. 2003. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J. Neurosci. 23:4967-74
200. Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, et al. 2006. Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314:664-66
201. Windebank AJ, Wood P, Bunge RP, Dyck PJ. 1985. Myelination determines the caliber of dorsal root ganglion neurons in culture. J. Neurosci. 5:1563-69
202. Yin X, Baek RC, Kirschner DA, Peterson A, Fujii Y, et al. 2006. Evolution of a neuroprotective function of central nervous system myelin. J. Cell Biol. 172:469-78
203. Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, et al. 1998. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 18:1953-62
204. Yin X, Kidd GJ, Pioro EP, McDonough J, Dutta R, et al. 2004. Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals. J. Neurosci. 24:3890-98
205. Yin X, Peterson J, Gravel M, Braun PE, Trapp BD. 1997. CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction. J. Neurosci. Res. 50:238-47
206. Yool DA, Klugmann M, McLaughlin M, Vouyiouklis DA, Dimou L, et al. 2 001. Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons. J. Neurosci. Res. 63:151-64
207. Zanazzi G, Einheber S, Westreich R, Hannocks MJ, Bedell-Hogan D, et al. 2001. Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. J. Cell Biol. 152:1289-99